Dr. Aneela A. Ali

Philosophy of care | Having been on the receiving end of multiple cancer diagnoses within my own family as I grew up, I strongly believe my patients and their families have the right to an honest discussion about their disease process. I personally make every effort to explain things in a simple yet detailed way, so patients understand their disease, goals of care and treatment plan. I want to be a trusted partner in helping them deal with their diagnosis, and make every effort to treat each patient as I would a family member. | Why I entered medicine | My family suffers from a genetic syndrome that predisposes them to developing cancer. Having grown up watching and helping most of the people I love deal with cancer, I decided to study medicine and do what I could to improve treatment and help others live their best possible lives with this disease. After medical school, I did basic science research at Johns Hopkins University, followed by residency and fellowship training at the Cleveland Clinic and the University of Pittsburgh, all to become the best oncologist I could be. | Community involvement | I am involved in organizations and charities that improve the lives and treatment of cancer patients. I also help provide free specialized remote care and expert opinion to international patients in collaboration with their local health care providers. I enjoy community events to educate people on targeted therapies and their success in making cancer a chronic disease. I also enjoy giving talks on how oncology is evolving and how cancer today often means patients living full lives while being treated for their disease. | Personal interests | Outside of work, I love to spend time with my family and our two dogs. Together we enjoy cooking, traveling, trying new cuisines and being outdoors. I also enjoy hunting and fishing. Dr. Ali is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Familial Colorectal Cancer, Anal Cancer, Colorectal Cancer, and Lynch Syndrome.

Rajiv Panikkar, MD, is the chair of the Geisinger Cancer Institute.|Dr. Panikkar was raised in Bloomsburg, Pa. He received his Doctor of Medicine degree from the University of Pittsburgh. He completed his residency in internal medicine at Virginia Commonwealth University Hospital, where he served as chief medical resident. His hematology/oncology fellowship was at Temple University Hospital/Fox Chase Cancer Center. He is board certified in hematology and oncology, and he practices as a medical oncologist.|Dr. Panikkar came to Geisinger in 2008 as a medical oncologist at Geisinger Medical Center. As chair of the Geisinger Cancer Institute, he currently leads 11 hematology/oncology, 6 radiation oncology and 4 palliative medicine sites across Pennsylvania. He is the principal investigator for Geisinger’s National Cancer Institute Community Research Program, a collaborative network designed to conduct oncology clinical trials and generate new knowledge through cancer care delivery research.|“The Geisinger Cancer Institute has an amazing opportunity to provide compassionate, patient-focused care close to home. We are expanding clinical trial opportunities and providing new medications and new technology to our communities. Our commitment to a team approach allows us to bring highly trained physicians together who are focused on the patient. Working at Geisinger is special — it has given me the opportunity to care for families I grew up with. I am excited about the growth of comprehensive services for the patients in our region."". Dr. Panikkar is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Arterial Embolism, and Familial Colorectal Cancer.

Pamela Landon is a Hematologist Oncology specialist and a Hematologist in Scranton, Pennsylvania. Dr. Landon is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. Her top areas of expertise are Vulvar Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Landon is currently accepting new patients.